ProPhase Labs, Inc. (PRPH) Reports Q3 Loss, Tops Revenue Estimates
Portfolio Pulse from
ProPhase Labs, Inc. (PRPH) reported a Q3 loss of $0.35 per share, which was larger than the Zacks Consensus Estimate of a $0.31 loss. However, the company exceeded revenue expectations.

November 13, 2024 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
ProPhase Labs reported a Q3 loss of $0.35 per share, missing the Zacks Consensus Estimate of a $0.31 loss. Despite this, the company exceeded revenue expectations.
The larger-than-expected loss per share could negatively impact investor sentiment, but the revenue beat may offset this. The net effect on the stock price is uncertain in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100